Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Piero Anversa retractions trigger trial pause

This week in cell therapy: Orchard Therapeutics closes US$225 million IPO and vision restored in blind rats following fetal cell transplant.

Go to the profile of RegMedNet
Nov 08, 2018

Please sign in or register for FREE

No comments yet.